Continuous ambulatory peritoneal dialysis complicated by Aureobasidium pullulans peritonitis.
We describe a case of peritonitis caused by Aureobasidium pullulans in a patient on continuous ambulatory peritoneal dialysis (CAPD). This dematiaceous fungus rarely causes infection in humans and to date has not been reported as an etiology of CAPD-associated peritonitis. The patient was managed successfully with peritoneal catheter removal and a prolonged course of intravenous amphotericin B, allowing resumption of CAPD. In vitro susceptibility testing confirmed sensitivity of this organism to amphotericin B.
Clark
E C
EC
Department of Medicine, Rochester General Hospital/Nephrology Unit, University of Rochester School of Medicine and Dentistry, NY 14621, USA.
Silver
S M
SM
Hollick
G E
GE
Rinaldi
M G
MG
D000328:Adult; D000666:Amphotericin B / Q000008:administration & dosage / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002404:Catheterization; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D009181:Mycoses / Q000628:therapy*; D010531:Peritoneal Dialysis, Continuous Ambulatory; D010538:Peritonitis / Q000188:drug therapy* / Q000382:microbiology
D000935:Antifungal Agents; D000666:Amphotericin B